Guo, Mengying
3 papers on CoChat
Most cited papers
- Verified
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Ji, L., Gao, L., Xue, H., Tian, J., Wang, K., Jiang, H., Huang, C., Lian, Q., Yuan, M., Gao, G., et al. (2025) · The Lancet Diabetes & Endocrinology
Pharmacology and Obesity TreatmentDiabetes Treatment and Management
Cited by 35
- Verified
Efficacy and safety of GLP-1 analog ecnoglutide in adults with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 2 trial
Zhu, D., Wang, W., Tong, G., Ma, G., Ma, J., Han, J., Zhang, X., Liu, Y., Gan, S., Qin, H., et al. (2024) · Nature Communications
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 34
- Verified
Meta-PKE: Memory-Enhanced Task-Adaptive Personal Knowledge Extraction in Daily Life
Zhong, Y., Wu, F., Guo, M., Zhang, X., Wang, M., & Wang, H. (2025) · Information Processing & Management
Topic ModelingWeb Data Mining and Analysis
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free